Phenotype
|
Fish
|
Conditions
|
Figures
|
heart tube mislocalised, abnormal
|
AB/TU + MO1-wwtr1
|
standard conditions
|
Figure 1
from Fillatre et al., 2019
|
determination of heart left/right asymmetry disrupted, abnormal
|
AB/TU + MO1-wwtr1
|
standard conditions
|
Figure 1
from Fillatre et al., 2019
|
heart jogging process quality, abnormal
|
AB/TU + MO1-wwtr1
|
standard conditions
|
Figure 1
from Fillatre et al., 2019
|
rhombomere 3 posterior margin rfng expression absent, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Figure 5
from Cayuso et al., 2019
|
thyroid follicle ab-t4 labeling spatial pattern, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 5
from Pappalardo et al., 2015
|
rhombomere 4 posterior margin rfng expression absent, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Figure 5
from Cayuso et al., 2019
|
whole organism tpo expression increased amount, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 4
from Pappalardo et al., 2015
|
whole organism slc5a5 expression increased amount, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 4
from Pappalardo et al., 2015
|
whole organism pax2a expression decreased amount, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 4
from Pappalardo et al., 2015
|
thyroid primordium tg expression increased amount, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 3
from Pappalardo et al., 2015
|
rhombomere 5 posterior margin rfng expression absent, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Figure 5
from Cayuso et al., 2019
|
posterior kidney cystic, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 3
from Tian et al., 2007
|
whole organism tg expression increased amount, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 4
from Pappalardo et al., 2015
|
thyroid follicle decreased diameter, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Table 1
from Pappalardo et al., 2015
|
rhombomere 6 posterior margin rfng expression absent, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Figure 5
from Cayuso et al., 2019
|
aortic arch dysplastic, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 7
from Pappalardo et al., 2015
|
whole organism curved ventral, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 3
from Tian et al., 2007
|
thyroid follicle spatial pattern, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 5
from Pappalardo et al., 2015
|
thyroid follicle decreased amount, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 5 ,
Fig. 6
from Pappalardo et al., 2015
|
rhombomere 1 posterior margin rfng expression absent, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Figure 5
from Cayuso et al., 2019
|
whole organism tshr expression decreased amount, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 4
from Pappalardo et al., 2015
|
pharyngeal vasculature morphology, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Fig. 7
from Pappalardo et al., 2015
|
rhombomere 2 posterior margin rfng expression absent, abnormal
|
WT + MO1-wwtr1
|
standard conditions
|
Figure 5
from Cayuso et al., 2019
|
pronephric proximal convoluted tubule straight, abnormal
|
WT + MO1-wwtr1 + MO4-tp53
|
standard conditions
|
Fig. 1
from Zhang et al., 2015
|
pronephric tubule orientation whole organism anterior-posterior axis, abnormal
|
WT + MO1-wwtr1 + MO4-tp53
|
standard conditions
|
Fig. 1
from Zhang et al., 2015
|
pronephric proximal convoluted tubule mislocalised posteriorly, abnormal
|
WT + MO1-wwtr1 + MO4-tp53
|
standard conditions
|
Fig. 1
from Zhang et al., 2015
|
pronephric proximal tubule development process quality, abnormal
|
WT + MO1-wwtr1 + MO4-tp53
|
standard conditions
|
Fig. 1
from Zhang et al., 2015
|
pronephric distal early tubule decreased length, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
control
|
Fig. 3 ,
Fig. 5
from Zhang et al., 2015
|
pronephric proximal convoluted tubule dilated, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
control
|
Fig. 3 ,
Fig. 5
from Zhang et al., 2015
|
pronephric duct malformed, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
standard conditions
|
Fig. 2
from Zhang et al., 2015
|
pronephric distal early tubule decreased length, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
chemical treatment by environment: retinoic acid
|
Fig. 5
from Zhang et al., 2015
|
pronephric proximal convoluted tubule increased length, exacerbated
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
chemical treatment by environment: retinoic acid
|
Fig. 5
from Zhang et al., 2015
|
pronephric distal late tubule increased length, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
chemical treatment: 4-(diethylamino)benzaldehyde
|
Fig. 5
from Zhang et al., 2015
|
pronephric proximal convoluted tubule dilated, exacerbated
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
chemical treatment by environment: retinoic acid
|
Fig. 5
from Zhang et al., 2015
|
pronephric proximal convoluted tubule increased length, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
control
|
Fig. 3 ,
Fig. 5
from Zhang et al., 2015
|
pronephric proximal convoluted tubule size, ameliorated
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
chemical treatment: 4-(diethylamino)benzaldehyde
|
Fig. 5
from Zhang et al., 2015
|
pronephric distal late tubule decreased length, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
standard conditions
|
Fig. 3
from Zhang et al., 2015
|
pronephric duct single ciliated epithelial cell decreased amount, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
standard conditions
|
Fig. 3
from Zhang et al., 2015
|
pronephric proximal straight tubule decreased length, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
control
|
Fig. 3 ,
Fig. 5
from Zhang et al., 2015
|
pronephric proximal convoluted tubule decreased length, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
chemical treatment: 4-(diethylamino)benzaldehyde
|
Fig. 5
from Zhang et al., 2015
|
trunk decreased length, abnormal
|
sqet11Et + MO1-wwtr1 + MO4-tp53
|
standard conditions
|
Fig. 2
from Zhang et al., 2015
|
post-vent region curved, abnormal
|
WT + MO1-pkd1b + MO1-wwtr1 + MO2-pkd1a
|
standard conditions
|
Fig. 7
from Merrick et al., 2018
|
mandibular arch skeleton morphology, abnormal
|
WT + MO1-pkd1b + MO1-wwtr1 + MO2-pkd1a
|
standard conditions
|
Fig. 7
from Merrick et al., 2018
|
mandibular arch skeleton bone mineralization decreased occurrence, abnormal
|
WT + MO1-pkd1b + MO1-wwtr1 + MO2-pkd1a
|
standard conditions
|
Fig. 7
from Merrick et al., 2018
|